Welcome to Crene Biotechnology!

+86-576-88205808

Catalog No CAS NO Product name
CR1054
1334714-66-7
Eravacycline(TP-434) dihydrochloride
Eravacycline dihydrochloride (TP-434 dihydrochloride) is a potent and broad-spectrum antibacterial agent.Eravacycline is poten..
CR1051
1286770-55-5
Verubecestat (MK-8931)
MK-8931 is a BACE1 inhibitor. MK-8931 binds significantly to β-secretase.MK-8931 is a BACE1 inhibitor. MK-8931 binds significantl..
CR1050
475108-18-0
Tivozanib AV-951
Tivozanib (AV-951; KRN951) is a highly potent and selective VEGFR 1/2/3 inhibitor with IC50s of 0.21, 0.16, and 0.24 nM in c..
CR1049
417716-92-8
Lenvatinib (E7080)
Lenvatinib is an orally active, multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, and..
CR1048
405169-16-6
Dovitinib (TKI-258, CHIR-258)
Dovitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1..
CR1047
288383-20-0
Cediranib(AZD2171)
Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, ..
CR1046
444731-52-6
Pazopanib
Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, ..
CR1045
635702-64-6
Pazopanib HCl (GW786034 HCl)
Pazopanib Hydrochloride is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fm..
CR1044
755037-03-7
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC5..
CR1043
656247-17-5
Nintedanib (BIBF 1120)
BIBF 1120 is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 n..
首页上一页当前第36/43页共428条记录每页10条3435363738下一页尾页
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China